vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and PRICESMART INC (PSMT). Click either name above to swap in a different company.

PRICESMART INC is the larger business by last-quarter revenue ($1.4B vs $749.2M, roughly 1.8× CLOVER HEALTH INVESTMENTS, CORP.). CLOVER HEALTH INVESTMENTS, CORP. runs the higher net margin — 3.6% vs 2.9%, a 0.7% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (62.0% vs 9.9%). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (45.0% CAGR vs 3.5%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

PriceSmart, Inc. is a United States based operator of membership warehouse clubs in Central America, the Caribbean, and South America. PriceSmart was founded by Sol and Robert Price, founders of Price Club; Robert Price is chairman of the board.

CLOV vs PSMT — Head-to-Head

Bigger by revenue
PSMT
PSMT
1.8× larger
PSMT
$1.4B
$749.2M
CLOV
Growing faster (revenue YoY)
CLOV
CLOV
+52.1% gap
CLOV
62.0%
9.9%
PSMT
Higher net margin
CLOV
CLOV
0.7% more per $
CLOV
3.6%
2.9%
PSMT
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
45.0%
3.5%
PSMT

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
CLOV
CLOV
PSMT
PSMT
Revenue
$749.2M
$1.4B
Net Profit
$27.3M
$40.2M
Gross Margin
17.7%
Operating Margin
3.6%
4.6%
Net Margin
3.6%
2.9%
Revenue YoY
62.0%
9.9%
Net Profit YoY
7.3%
EPS (diluted)
$0.05
$1.29

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
PSMT
PSMT
Q1 26
$749.2M
Q4 25
$487.7M
$1.4B
Q3 25
$496.6M
$1.3B
Q2 25
$477.6M
$1.3B
Q1 25
$462.3M
$1.4B
Q4 24
$337.0M
$1.3B
Q3 24
$331.0M
$1.2B
Q2 24
$356.3M
$1.2B
Net Profit
CLOV
CLOV
PSMT
PSMT
Q1 26
$27.3M
Q4 25
$-49.3M
$40.2M
Q3 25
$-24.4M
$31.5M
Q2 25
$-10.6M
$35.2M
Q1 25
$-1.3M
$43.8M
Q4 24
$-22.1M
$37.4M
Q3 24
$-9.2M
$29.1M
Q2 24
$7.4M
$32.5M
Gross Margin
CLOV
CLOV
PSMT
PSMT
Q1 26
Q4 25
17.7%
Q3 25
Q2 25
Q1 25
17.1%
Q4 24
17.4%
Q3 24
24.5%
Q2 24
30.3%
Operating Margin
CLOV
CLOV
PSMT
PSMT
Q1 26
3.6%
Q4 25
-10.1%
4.6%
Q3 25
-4.9%
4.0%
Q2 25
-2.2%
4.3%
Q1 25
-0.3%
4.8%
Q4 24
-6.4%
4.6%
Q3 24
-2.7%
4.0%
Q2 24
2.0%
4.1%
Net Margin
CLOV
CLOV
PSMT
PSMT
Q1 26
3.6%
Q4 25
-10.1%
2.9%
Q3 25
-4.9%
2.4%
Q2 25
-2.2%
2.7%
Q1 25
-0.3%
3.2%
Q4 24
-6.6%
3.0%
Q3 24
-2.8%
2.4%
Q2 24
2.1%
2.6%
EPS (diluted)
CLOV
CLOV
PSMT
PSMT
Q1 26
$0.05
Q4 25
$1.29
Q3 25
$1.02
Q2 25
$1.14
Q1 25
$1.45
Q4 24
$1.21
Q3 24
$0.94
Q2 24
$1.08

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
PSMT
PSMT
Cash + ST InvestmentsLiquidity on hand
$177.6M
$320.6M
Total DebtLower is stronger
$180.3M
Stockholders' EquityBook value
$339.4M
$1.3B
Total Assets
$697.7M
$2.4B
Debt / EquityLower = less leverage
0.14×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
PSMT
PSMT
Q1 26
$177.6M
Q4 25
$78.3M
$320.6M
Q3 25
$314.2M
Q2 25
$262.4M
Q1 25
$247.3M
Q4 24
$194.5M
$222.2M
Q3 24
$288.0M
$225.5M
Q2 24
$254.8M
$228.2M
Total Debt
CLOV
CLOV
PSMT
PSMT
Q1 26
Q4 25
$180.3M
Q3 25
$186.6M
Q2 25
$103.1M
Q1 25
$107.1M
Q4 24
$115.6M
Q3 24
$130.4M
Q2 24
$135.1M
Stockholders' Equity
CLOV
CLOV
PSMT
PSMT
Q1 26
$339.4M
Q4 25
$308.7M
$1.3B
Q3 25
$340.9M
$1.2B
Q2 25
$344.2M
$1.2B
Q1 25
$336.1M
$1.2B
Q4 24
$341.1M
$1.2B
Q3 24
$342.2M
$1.1B
Q2 24
$324.9M
$1.1B
Total Assets
CLOV
CLOV
PSMT
PSMT
Q1 26
$697.7M
Q4 25
$541.0M
$2.4B
Q3 25
$559.7M
$2.3B
Q2 25
$575.0M
$2.1B
Q1 25
$583.7M
$2.1B
Q4 24
$580.7M
$2.1B
Q3 24
$653.0M
$2.0B
Q2 24
$674.2M
$2.0B
Debt / Equity
CLOV
CLOV
PSMT
PSMT
Q1 26
Q4 25
0.14×
Q3 25
0.15×
Q2 25
0.08×
Q1 25
0.09×
Q4 24
0.10×
Q3 24
0.12×
Q2 24
0.12×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
PSMT
PSMT
Operating Cash FlowLast quarter
$71.2M
Free Cash FlowOCF − Capex
$32.6M
FCF MarginFCF / Revenue
2.4%
Capex IntensityCapex / Revenue
2.8%
Cash ConversionOCF / Net Profit
1.77×
TTM Free Cash FlowTrailing 4 quarters
$125.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
PSMT
PSMT
Q1 26
Q4 25
$-66.9M
$71.2M
Q3 25
$12.1M
$82.1M
Q2 25
$5.4M
$52.8M
Q1 25
$-16.3M
$87.9M
Q4 24
$34.8M
$38.5M
Q3 24
$50.0M
$41.8M
Q2 24
$44.8M
$38.1M
Free Cash Flow
CLOV
CLOV
PSMT
PSMT
Q1 26
Q4 25
$-69.0M
$32.6M
Q3 25
$11.4M
$25.6M
Q2 25
$4.8M
$14.0M
Q1 25
$-16.5M
$53.2M
Q4 24
$33.3M
$10.3M
Q3 24
$49.6M
$15.2M
Q2 24
$44.4M
$-308.0K
FCF Margin
CLOV
CLOV
PSMT
PSMT
Q1 26
Q4 25
-14.1%
2.4%
Q3 25
2.3%
1.9%
Q2 25
1.0%
1.1%
Q1 25
-3.6%
3.9%
Q4 24
9.9%
0.8%
Q3 24
15.0%
1.2%
Q2 24
12.5%
-0.0%
Capex Intensity
CLOV
CLOV
PSMT
PSMT
Q1 26
Q4 25
0.4%
2.8%
Q3 25
0.1%
4.2%
Q2 25
0.1%
2.9%
Q1 25
0.0%
2.5%
Q4 24
0.5%
2.2%
Q3 24
0.1%
2.2%
Q2 24
0.1%
3.1%
Cash Conversion
CLOV
CLOV
PSMT
PSMT
Q1 26
Q4 25
1.77×
Q3 25
2.60×
Q2 25
1.50×
Q1 25
2.01×
Q4 24
1.03×
Q3 24
1.44×
Q2 24
6.04×
1.17×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLOV
CLOV

Segment breakdown not available.

PSMT
PSMT

Fresh Foods$454.9M33%
Caribbean Operations Segment$396.5M29%
Colombia Operations Segment$204.1M15%
Hardlines$162.6M12%
Softlines$99.8M7%
ship Income Member$24.5M2%
Health Services$14.5M1%
Other Revenue And Income$4.2M0%
United States Operations Segment$510.0K0%
Export Sales$359.0K0%

Related Comparisons